AXL and lung cancer: Treatment with a pan-TAM inhibitor, RXDX-106, significantly increased the level of NK cell infiltration in a mouse model of colon cancer [47], and treatment with the Axl inhibitor R428 was able to sensitize lung cancer cells to NK cell-mediated cytotoxicity [54].